Anuh Pharma Ltd. — Investor Relations & Filings
Anuh Pharma Ltd. is a manufacturer of Active Pharmaceutical Ingredients (APIs) and bulk drugs, specializing in the production of Macrolides, including Erythromycin salts, Azithromycin, and Clarithromycin. Its product portfolio also encompasses Anti-TB agents such as Pyrazinamide and Ethambutol, Anti-malarials like Chloroquine Phosphate, and a range of Corticosteroids including Dexamethasone and Betamethasone. Operating with global quality standards, the company maintains certifications such as WHO-GMP, EU-GMP, and CEP. Anuh Pharma focuses on large-scale manufacturing and the supply of high-quality intermediates to pharmaceutical formulators worldwide. The organization leverages advanced chemical synthesis capabilities to serve diverse therapeutic segments, ensuring consistent supply chain reliability and regulatory compliance across international markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Updates | 2026-05-04 | English | |
| Copy of Newspaper Publication | 2026-04-28 | English | |
| Copy of Newspaper Publication | 2026-04-17 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | |
| Trading Window | 2026-03-27 | English | |
| Updates | 2026-03-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42196667 | Updates | 2026-05-04 | English | ||
| 42207313 | Copy of Newspaper Publication | 2026-04-28 | English | ||
| 42209157 | Copy of Newspaper Publication | 2026-04-17 | English | ||
| 42191917 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | ||
| 42219951 | Trading Window | 2026-03-27 | English | ||
| 42192070 | Updates | 2026-03-06 | English | ||
| 42174440 | Copy of Newspaper Publication | 2026-02-18 | English | ||
| 42240950 | Investor Presentation | 2026-02-13 | English | ||
| 42264135 | Copy of Newspaper Publication | 2026-02-08 | English | ||
| 42278100 | Updates | 2026-02-06 | English | ||
| 42278563 | Updates | 2026-02-06 | English | ||
| 42279825 | Outcome of Board Meeting | 2026-02-06 | English | ||
| 42280996 | Outcome of Board Meeting | 2026-02-06 | English | ||
| 43929364 | Board Meeting — Board Meeting Intimation | 2026-02-02 | English | ||
| 43929407 | Board Meeting — Financial Results/Other business matters | 2026-02-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BBS-Bioactive Bone Substitutes Oyj
Develops and manufactures bioactive medical implants for or…
|
BONE | FI | Manufacturing |
|
BCWORLDPHARM Co., Ltd.
Pharmaceutical company specializing in the R&D and manufact…
|
200780 | KR | Manufacturing |
|
BDH Industries Ltd.
WHO-GMP certified manufacturer of diverse therapeutic formu…
|
524828 | IN | Manufacturing |
|
Beam Therapeutics Inc.
Develops precision genetic medicines using proprietary base…
|
BEAM | US | Manufacturing |
|
Bedrocan Cannabis Corp.
EU-GMP certified producer of standardized medicinal cannabi…
|
BED | CA | Manufacturing |
|
Beihai Gofar Chuanshan Biological Co., Ltd.
Produces marine biological products and chitin derivatives …
|
600538 | CN | Manufacturing |
|
BEIJING AOSAIKANG PHARMACEUTICAL CO.,LTD
Research-driven pharmaceutical firm specializing in oncolog…
|
002755 | CN | Manufacturing |
|
Beijing Beilu Pharmaceutical Co.,Ltd
Specializes in contrast media, CNS treatments, and metaboli…
|
300016 | CN | Manufacturing |
|
Beijing Biostar Pharmaceuticals Co., Ltd.
Biopharma company using synthetic biology to develop novel …
|
2563 | HK | Manufacturing |
|
Beijing Bohui Innovation Biotechnology Group Co., Ltd
Develops medical diagnostic systems, mass spectrometry, and…
|
300318 | CN | Manufacturing |
Anuh Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61478/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61478 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61478 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61478 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61478}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Anuh Pharma Ltd. (id: 61478)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.